CellCentric
ID: 5638427Developer of p300/CBP small-molecule inhibitor drug to treat cancer.
14
Funding Rounds
$243.5m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company CellCentric has raised a total of $172m in funding over 14 rounds.
Key Insights:
- CellCentric Series C Round, May 2025: $120m
- CellCentric , May 2018: $26m
- Cellcentric Limited , May 2018: $26m
- CellCentric Venture round, October 2020: $33m
- CellCentric Venture round, May 2018: $26m
- CellCentric Venture round, June 2013: $5.97m
- CellCentric Grant (money), May 2010: $600.72k
- CellCentric Venture round, October 2007: $4.3m
- CellCentric Venture round, July 2006: $1.67m
CellCentric Grant (money), May 2010
$600.72k
Industries
CellCentric is active in the following industries: